NYSE:SOLV - New York Stock Exchange, Inc. - US83444M1018 - Common Stock - Currency: USD
71.73
+0.37 (+0.52%)
The current stock price of SOLV is 71.73 USD. In the past month the price decreased by -8.62%. In the past year, price increased by 25.16%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ALC | ALCON INC | 29.29 | 43.91B | ||
COO | COOPER COS INC/THE | 18.27 | 14.14B | ||
ALGN | ALIGN TECHNOLOGY INC | 14.51 | 9.89B | ||
MMSI | MERIT MEDICAL SYSTEMS INC | 23.16 | 5.01B | ||
LNTH | LANTHEUS HOLDINGS INC | 10.66 | 4.88B | ||
BLCO | BAUSCH + LOMB CORP | 32.14 | 4.78B | ||
HAE | HAEMONETICS CORP/MASS | 16.36 | 3.59B | ||
ICUI | ICU MEDICAL INC | 18.25 | 3.14B | ||
XRAY | DENTSPLY SIRONA INC | 8.51 | 2.85B | ||
UFPT | UFP TECHNOLOGIES INC | 27.73 | 1.75B | ||
ESTA | ESTABLISHMENT LABS HOLDINGS | N/A | 1.20B | ||
NEOG | NEOGEN CORP | 14.12 | 1.01B |
Solventum Corp. operates as a health care company. The company is headquartered in St. Paul, Minnesota and currently employs 22,000 full-time employees. The company went IPO on 2024-03-26. The firm's segments include MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. MedSurg segment provides solutions including negative pressure wound therapy, advanced wound dressings, advanced skin care, and others. Dental Solutions segment provides a suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. Health Information Systems segment provides healthcare systems with software solutions, including computer-assisted physician documentation, direct-to-bill and coding automation, and data visualization platforms. Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes.
SOLVENTUM CORP
C/O 3M Company, 3M Center, Building 275-6W-02
ST. PAUL MINNESOTA US
Employees: 22000
Phone: 16517331110
The current stock price of SOLV is 71.73 USD. The price increased by 0.52% in the last trading session.
The exchange symbol of SOLVENTUM CORP is SOLV and it is listed on the New York Stock Exchange, Inc. exchange.
SOLV stock is listed on the New York Stock Exchange, Inc. exchange.
19 analysts have analysed SOLV and the average price target is 86.74 USD. This implies a price increase of 20.93% is expected in the next year compared to the current price of 71.73. Check the SOLVENTUM CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SOLVENTUM CORP (SOLV) has a market capitalization of 12.41B USD. This makes SOLV a Large Cap stock.
SOLVENTUM CORP (SOLV) currently has 22000 employees.
SOLVENTUM CORP (SOLV) has a support level at 70.81 and a resistance level at 71.9. Check the full technical report for a detailed analysis of SOLV support and resistance levels.
The Revenue of SOLVENTUM CORP (SOLV) is expected to grow by 2.33% in the next year. Check the estimates tab for more information on the SOLV EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SOLV does not pay a dividend.
SOLVENTUM CORP (SOLV) will report earnings on 2025-08-07, after the market close.
The PE ratio for SOLVENTUM CORP (SOLV) is 12.06. This is based on the reported non-GAAP earnings per share of 5.95 and the current share price of 71.73 USD. Check the full fundamental report for a full analysis of the valuation metrics for SOLV.
The outstanding short interest for SOLVENTUM CORP (SOLV) is 2.78% of its float. Check the ownership tab for more information on the SOLV short interest.
ChartMill assigns a technical rating of 1 / 10 to SOLV. When comparing the yearly performance of all stocks, SOLV is one of the better performing stocks in the market, outperforming 77.16% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to SOLV. SOLV has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months SOLV reported a non-GAAP Earnings per Share(EPS) of 5.95. The EPS decreased by -76.29% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 4.56% | ||
ROA | 2.61% | ||
ROE | 11.62% | ||
Debt/Equity | 2.4 |
ChartMill assigns a Buy % Consensus number of 71% to SOLV. The Buy consensus is the average rating of analysts ratings from 19 analysts.
For the next year, analysts expect an EPS growth of -14.97% and a revenue growth 2.33% for SOLV